A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants

NCT05288816 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Alexion Pharmaceuticals, Inc.